These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2122781)
21. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease. Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397 [TBL] [Abstract][Full Text] [Related]
22. High dietary fat feeding during perinatal development of rats alters hepatic drug metabolism of progeny. Karnik HB; Sonawane BR; Adkins JS; Mohla S Dev Pharmacol Ther; 1989; 14(2):135-40. PubMed ID: 2517107 [TBL] [Abstract][Full Text] [Related]
23. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats. Gupta PH; Mehta S; Mehta SK Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773 [TBL] [Abstract][Full Text] [Related]
24. Hepatic microsomal mixed-function oxidases in rats exposed to high ambient temperature. Pachecka J; Kobylińska K; Miaskiewicz H; Bicz W Acta Physiol Pol; 1983; 34(5-6):563-8. PubMed ID: 6679992 [TBL] [Abstract][Full Text] [Related]
25. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related]
26. [Microsomal oxidation system in the course of development and aging]. Lemeshko VV Biokhimiia; 1980 Nov; 45(11):1964-9. PubMed ID: 6786371 [TBL] [Abstract][Full Text] [Related]
27. [Effect of the cholesterol and protein diet on cytochrome P-450 dependent monooxygenase activity]. Plewka A; Kamiński M Med Pr; 1995; 46(1):17-23. PubMed ID: 9732843 [TBL] [Abstract][Full Text] [Related]
28. Effects of cold preservation and reperfusion on microsomal cytochrome P-450-linked monooxygenase system of the rat liver. Izuishi K; Ichikawa Y; Hossain MA; Maeba T; Maeta H; Tanaka S J Surg Res; 1996 Mar; 61(2):361-6. PubMed ID: 8656609 [TBL] [Abstract][Full Text] [Related]
29. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Sharer JE; Shipley LA; Vandenbranden MR; Binkley SN; Wrighton SA Drug Metab Dispos; 1995 Nov; 23(11):1231-41. PubMed ID: 8591724 [TBL] [Abstract][Full Text] [Related]
30. Studies on the incubation mixtures for the in vitro mutagenesis test with metabolic activation (microsomal assay) = 2. Behaviour of cytochromes P-450, P-420, b5, of NADPH-CYT. C-reductases, and p-nitroanisole demethylase. Bauer C; Leporini C; Bronzetti G; Nieri R; Tonarelli S; Corsi C; Del Carratore R Boll Soc Ital Biol Sper; 1981 Jan; 57(1):70-5. PubMed ID: 6788052 [TBL] [Abstract][Full Text] [Related]
31. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450. Nebbia C; Ceppa L; Dacasto M; Carletti M J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365 [TBL] [Abstract][Full Text] [Related]
32. Effect of sulfamethazine on mixed function oxidase in chickens. Kodam KM; Govindwar SP Vet Hum Toxicol; 1995 Aug; 37(4):340-2. PubMed ID: 8540224 [TBL] [Abstract][Full Text] [Related]
33. [Comparison of the activities of the hepatic and renal mixed function oxidase (MFO) systems in rats during different postnatal periods of life]. Czekaj P; Plewka A Folia Med Cracov; 1990; 31(3):225-36. PubMed ID: 2129035 [TBL] [Abstract][Full Text] [Related]
34. [Effect of nicotinic acid and nicotinamide on the activity of NADPH- and NADH-dependent redox chains in rat liver endoplasmic reticulum]. Lukienko PI; Bushma MI Farmakol Toksikol; 1982; 45(2):78-81. PubMed ID: 6210571 [TBL] [Abstract][Full Text] [Related]
35. Distribution of enzymes involved in metabolism of polycyclic aromatic hydrocarbons among rat liver endomembranes and plasma membranes. Stasiecki P; Oesch F; Bruder G; Jarasch ED; Franke WW Eur J Cell Biol; 1980 Apr; 21(1):79-92. PubMed ID: 6769676 [TBL] [Abstract][Full Text] [Related]
36. Hepatic cytochrome P-450. Paine AJ Essays Biochem; 1981; 17():85-126. PubMed ID: 6795037 [No Abstract] [Full Text] [Related]
37. [Interaction of 2,6-dimethyl-3,5-dicarbethoxy-1,4-dihydropyridine with enzymes of the NADP.H2-specific electron transport chain of rat liver microsomes]. Sniedze TN; Shtokman AP; Kiseleva VN; Kagen TI; Gilev AP Biull Eksp Biol Med; 1977 Jun; 83(6):671-3. PubMed ID: 406948 [TBL] [Abstract][Full Text] [Related]
38. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats. Kato Y; Kimura R Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800 [TBL] [Abstract][Full Text] [Related]
39. Regulative mechanisms in NADH- and NADPH-supported N-oxidation of 4-chloroaniline catalyzed by cytochrome b5-enriched rabbit liver microsomal fractions. Golly I; Hlavica P Biochim Biophys Acta; 1987 Jun; 913(2):219-27. PubMed ID: 3109485 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of hepatic mixed-function oxidase enzymes in mice by acute and chronic treatment with selenium. Ishikawa M; Sasaki M; Koiwai K; Ozaki M; Takayanagi Y; Sasaki K J Pharmacobiodyn; 1992 Aug; 15(8):377-85. PubMed ID: 1479537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]